AnalystsTrevor AllredTrevor Allred's Stock Forecasts
AnalystsTrevor Allred
Sectors:
Industries:
Analyst Ranking
Top 23%
#1177 out of 5177 analysts
Average Return
+45.8%
Win Rate
71%10 out of 14
Risk vs Reward
Poor
Good
Trevor Allred's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mbx Biosciences IncMBX | +226.07% | $12.43 | $40.53 | 2025-07-16 - 2026-01-16 | Buy |
Mbx Biosciences IncMBX | +113.77% | $18.96 | $40.53 | 2025-09-23 - 2026-01-16 | Buy |
Ligand Pharmaceuticals IncLGND | +84.70% | $104.48 | $192.97 | 2025-05-09 - 2026-01-16 | Buy |
Palvella Therapeutics IncPVLA | +75.86% | $56.71 | $99.73 | 2025-09-09 - 2026-01-16 | Buy |
Ligand Pharmaceuticals IncLGND | +57.87% | $122.23 | $192.97 | 2025-02-28 - 2026-01-16 | Buy |
Trevor Allred Analyst Color
Get additional color on Trevor Allred's coverage of popular stocks
Trevor Allred's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Legend Biotech CorpLEGN | 1 | Buy | $75.00 | +238.75% | Initiates Coverage On | 10 days ago |
Design Therapeutics IncDSGN | 1 | Buy | $18.00 | +93.97% | Initiates Coverage On | 10 days ago |
Theravance Biopharma IncTBPH | 1 | Buy | $27.00 | +34.93% | Initiates Coverage On | a month ago |
Ligand Pharmaceuticals IncLGND | 7 | Buy | $275.00 | +42.51% | Maintains | 2 months ago |
Mbx Biosciences IncMBX | 2 | Buy | $80.00 | +97.38% | Maintains | 4 months ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $85.00 | -14.77% | Initiates Coverage On | 4 months ago |
Innoviva IncINVA | 1 | Buy | $35.00 | +80.04% | Initiates Coverage On | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.